# Fate Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fate-therapeutics

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Website: www.fatetherapeutics.com
- Total disclosed funding: $45M
- Latest round: Series C (May 4, 2012)
- Investors on record: 6

## About

Founded in 2007 and based in California, US, Fate Therapeutics, Inc. engages in research and development of stem cell therapeutics for the treatment of cancer and immune disorders.

## Funding rounds

- Series C, May 4, 2012 — Polaris Partners
- Series B, Nov 16, 2009, $30M — ARCH Venture Partners, OVP Venture Partners, Polaris Partners, Venrock, Astellas Venture Management, Sanofi Ventures
- Series A, Nov 1, 2007, $15M — ARCH Venture Partners, OVP Venture Partners, Polaris Partners, Venrock

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B
- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Series A, Series B
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A, Series B, Series C
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A, Series B
- Astellas Venture Management (https://capitalatlas.ai/funds/astellas-venture-management) — Series B
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series B